A growing number of clinicians rely on AdaptDx to detect age-related macular degeneration in their adult patients. Our customers tell the story of how they’re fighting against blindness caused by AMD.
Starting therapy early may have huge benefits when we project forward another 10 or 20 years. I believe this device is helping me save vision for many people.
The MacuLogix team gives the most superior installation, education, and support of any ophthalmologic instrument that I can think of. By discussing and identifying your personal practice flow, recommendations and support will be given to best start making this a reflex to discuss with patients and perform in your office on a daily basis.
If you want to impact your patient base in a very positive way by diagnosing and treating macular degeneration at the earliest stages possible to best preserve long term vision, then the AdaptDx is an absolute necessity. There is no other way to diagnose macular degeneration so early, including by the best dilated examination and imaging you can give as an eye doctor. Think of it this way…you go to your PCP once per year. And once per year your PCP orders lab work to look for disease that is asymptomatic and undetectable to them in any other way in the early stages (high cholesterol, diabetes, thyroid dysfunction). This is what the AdaptDx can do for your patients.
The marketing package MacuLogix provides to their customers is the best I have seen with any equipment company!
AdaptDx may find macular degeneration at least three years before you actually see any clinical signs. Do you want to wait to diagnose glaucoma until someone has a vision-threatening visual field loss? No, you don’t. And we should be thinking the same way about AMD. Let’s find it in its earliest stage so that we can do something about it and try to prevent the bad outcomes.
Since incorporating AdaptDx in our office we can tell patients that even though they have a family history or are concerned about the disease, we have a device that can help detect it before it is too late. Diagnosing AMD at the subclinical level gives us a plan of action for treatment. Having this plan brings comfort to not only myself but the patients so they can walk out my practice doors with a newfound confidence in their future.
In the first few months of using the AdaptDx, we've more than doubled our nutraceutical sales and have seen a sizable increase in optical sales associated with UV and blue light blocking protection.
AdaptDx has really helped me care for my patients. It has helped me find macular degeneration a lot earlier and be able to proactively treat this for my patients.
When we started using the AdaptDx, we weren’t sure how the technology was going to be received. But we found that using it in the office has made us better clinicians and has improved the quality of life for our patients. I honestly can’t see myself practicing without the AdaptDx at this point.
I have been in eye care since the late 90s and I remember that macular degeneration was just a condition that was very difficult to detect and even once detected, difficult to do anything about it. So essentially we were just watching patients go blind. Now that we have the AdaptDx it’s made a world of a difference in diagnosing patients.